Nutex Health Inc.: Form 10-Q for the period ended Mar 31, 2015
Filed with the SEC on May 14, 2015 and accepted by EDGAR at May 14, 2015, 16:13 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2015-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2015-01-01 to 2015-03-31 | $300.3k | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months2015-01-01 to 2015-03-31 | $135.6k | us-gaap:CostOfRevenue |
| Gross profit | 3 months2015-01-01 to 2015-03-31 | $164.7k | us-gaap:GrossProfit |
| Operating income | 3 months2015-01-01 to 2015-03-31 | −$143.2k | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2015-01-01 to 2015-03-31 | −$1.7k | us-gaap:InterestExpense |
| Net income | 3 months2015-01-01 to 2015-03-31 | −$144.9k | us-gaap:NetIncomeLoss |
| Operating cash flow | 3 months2015-01-01 to 2015-03-31 | −$119.9k | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2015-01-01 to 2015-03-31 | −$5.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2015-03-31 | $38.7k | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2015-03-31 | $169.7k | us-gaap:AssetsCurrent |
| Total assets | At period end2015-03-31 | $194.0k | us-gaap:Assets |
| Current liabilities | At period end2015-03-31 | $331.4k | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | At period end2015-03-31 | −$137.4k | us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest |
Source: SEC EDGAR, the filing index for accession 0001211524-15-000055. Last ingested by Listed: Nov 14, 2026, 12:46 ET. Listed shows no prices and gives no investment advice.